A Letter from Jackie D. Hancock, Jr.

November 14, 2013

For the past nine years, it has been my pleasure to lead and serve the National Foundation for Transplants. The foundation has accomplished many milestones along the way, and it is poised for a terrific future.

Recently, I accepted a new professional challenge and have been named the new CEO of the PKD Foundation headquartered in Kansas City, MO. Polycystic kidney disease (PKD) affects more than 600,000 Americans, and many NFT patients have a PKD diagnosis.

In my new role, I’ll be particularly focused on research efforts that will hopefully lead to a cure, or at the very least, a better way of treating the disease. Currently, the only cure for PKD is a kidney transplant, and I know I will still count on my colleagues at NFT to assist my new patients.

Your help and support for NFT over the years has been a true blessing. I trust that your relationship with NFT will continue. Our new leader, Connie Gonitzke, has been my trusted advisor and “my voice of reason” for many years. NFT is in very capable hands.

There are many things I’ll miss about NFT, including the staff that I was fortunate to be part of and the professional transplant community of physicians, social workers and financial coordinators. But most of all, I’ll miss the patients and their families. I’ll miss hearing about their triumphs; how they once again overcame adversity; and how they always keep hope alive even in the face of life-altering circumstances.

I always sign letters to our new patients with “Best wishes on your journey to transplant.” It’s not a tag line. It’s a hope for the future. It is the hope that for every single patient a transplant is near and successful.

And so this time, I’ll sign off by simply saying thanks. Thanks for all the encouraging phone calls, e-mails and handwritten notes. They have meant so much to me since 2004.

I have been pleased and honored to be worthy of your support.


Jackie D. Hancock, Jr.

President and CEO